alphaveAKUMS₹750.00

Akums Drugs and Pharmaceuticals Ltd.

₹ CrorePeersALIVUS AGARWALEYE ADVENZYMES APLLTD AARTIPHARM AARTIDRUGS CORONA HCGMcap ₹11,483 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,390.2	1,448.3	1,448.3
+ Capital Work-in-Progress	159.6	176.7	176.7
+ Goodwill	2.1	2.1	2.1
+ Other Intangibles	5.1	5.5	5.5
+ Intangibles under Development	3.2	0.7	0.7
+ Non-current Investments	0.1	0.1	0.1
+ Other Non-current Financial Assets	33.6	29.3	29.3
Non-current Financial Assets	33.7	29.5	29.5
+ Deferred Tax Assets	208.1	170.9	170.9
+ Other Non-current Assets	36.9	53.6	53.6
Total Non-current Assets	1,838.8	1,887.1	1,887.1
Current Assets
+ Inventories	680.9	755.7	755.7
+ Trade Receivables	770.3	796.6	796.6
+ Cash & Cash Equivalents	101.2	386.0	386.0
+ Other Bank Balances	475.3	1,294.6	1,294.6
+ Other Current Financial Assets	48.1	29.6	29.6
Current Financial Assets	1,394.9	2,506.7	2,506.7
+ Other Current Assets	198.8	297.4	297.4
Total Current Assets	2,274.6	3,559.9	3,559.9
Total Assets	4,113.4	5,447.0	5,447.0
Equity
+ Equity Share Capital	30.6	30.6	30.6
+ Other Equity / Reserves	3,016.4	3,282.7	3,282.7
Equity — Owners of Parent	3,047.0	3,313.3	3,313.3
+ Minority Interest	16.6	17.8	17.8
Total Equity	3,063.6	3,331.1	3,331.1
Liabilities
+ Other Non-current Financial Liab	34.2	114.0	114.0
Non-current Financial Liabilities	34.2	114.0	114.0
+ Provisions — Non-current	35.9	48.6	48.6
+ Deferred Tax Liabilities	18.6	17.7	17.7
+ Other Non-current Liabilities	67.3	840.8	840.8
Non-current Liabilities	156.1	1,021.1	1,021.1
+ Borrowings — Current	13.7	73.0	73.0
+ Trade Payables	642.8	602.2	602.2
+ Other Current Financial Liab	140.6	141.3	141.3
Current Financial Liabilities	797.0	816.4	816.4
+ Provisions — Current	57.2	65.4	65.4
+ Current Tax Liabilities	0.4	8.9	8.9
+ Other Current Liabilities	39.1	204.0	204.0
Current Liabilities	893.7	1,094.8	1,094.8
Total Liabilities	1,049.8	2,115.8	2,115.8
Total Equity & Liabilities	4,113.4	5,447.0	5,447.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	77.2	88.0	88.0
+ Dues to Other Creditors — Current	565.6	514.2	514.2

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.